Search results
From debilitating illness to a 'normal' life, new gene therapy treatment promises to transform rare...
USA TODAY via Yahoo News· 2 years agoFor the first time in her life, 19-year-old Antonela Baron can imagine what it might be not to be...
Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics
Motley Fool via Yahoo Finance· 5 months agoCRISPR Therapeutics (NASDAQ: CRSP) already had a huge 2023. The biotech scored its first product...
Bluebird bio's gene therapy for blood disorder gets FDA panel backing
Reuters via Yahoo News· 2 years ago(Reuters) -Bluebird bio's treatment for a rare blood disorder received backing from advisers to the...
Understanding MCHC Blood Test Results
Health via Yahoo News· 1 year agoThe blood test can be helpful in diagnosing anemia. Medically reviewed by Steffini Stalos, DO Mean corpuscular hemoglobin concentration (MCHC) is a...
FDA approves $2.8m gene therapy treatment for rare blood disorder
The Hill via Yahoo News· 2 years agoThe Food and Drug Administration (FDA) on Wednesday approved the first gene therapy treatment that...
Here Are the New Drugs and Treatments We Could See in 2024
Time via Yahoo News· 5 months agoCredit - Getty Images 2023 was a strong year for innovative new drugs, with new medications for...
Hemochromatosis (Iron Overload): What to Know
Verywell Health via Yahoo News· 3 months agoA condition that causes excess iron accumulation in the body Medically reviewed by Benjamin Leach, MD Hemochromatosis is a medical condition where people...
Dr. Jeff Hersh explains what causes anemia and options on how it can be treated
The Metrowest Daily News via Yahoo News· 7 months agoQ: What causes anemia, and is a blood transfusion the only treatment? A: Red blood cells are a...
FDA Committee Endorses bluebird's (BLUE) Thalassemia Therapy
Zacks via Yahoo Finance· 2 years agoAn FDA advisory committee favors approval for bluebird bio's (BLUE) beti-cel to treat...
Pfizer to end license deal with Syros for blood disorder therapies
Reuters via AOL· 11 months agoShares of Syros were down 5.7% in trading after the bell. The termination will end the company's...